Metastatic Intrahepatic Cholangiocarcinoma

Drug	Drug Name	Drug Description
DB15149	Futibatinib	A kinase inhibitor used to treat intrahepatic cholangiocarcinoma in previously treated adults.

Drug	Drug Name	Target	Type
DB15149	Futibatinib	Cytochrome P450 3A4	enzyme
DB15149	Futibatinib	P-glycoprotein 1	transporter
DB15149	Futibatinib	ATP-binding cassette sub-family G member 2	transporter
DB15149	Futibatinib	Serum albumin	carrier
DB15149	Futibatinib	Alpha-1-acid glycoprotein 1	carrier
DB15149	Futibatinib	Cytochrome P450 2C9	enzyme
DB15149	Futibatinib	Cytochrome P450 2D6	enzyme
DB15149	Futibatinib	Fibroblast growth factor receptor 1	target
DB15149	Futibatinib	Fibroblast growth factor receptor 2	target
DB15149	Futibatinib	Fibroblast growth factor receptor 3	target
DB15149	Futibatinib	Fibroblast growth factor receptor 4	target

Drug	Drug Name	Phase	Status	Count
DB15387	Bintrafusp alfa	1	Active Not Recruiting	1
DB11595	Atezolizumab	2	Active Not Recruiting	1
DB00515	Cisplatin	2	Recruiting	1
DB05239	Cobimetinib	2	Active Not Recruiting	1
DB11714	Durvalumab	2	Recruiting	1
DB00441	Gemcitabine	2	Recruiting	1
DB11930	Varlilumab	2	Active Not Recruiting	1